Exhibit 16.1 Letter from Eisner LLP pursuant to Item 304(a)(3) of Regulation S-B. Eisner LLP Accountants and Advisors Eisner 750 Third Avenue New York, NY 10017-2703 Tel 212.949.8700 Fax 212.891.4100 www.eisnerllp.com February 24, 2005 United States Securities & Exchange Commission Division of Corporate Finance 450 Fifth Street, N.W. Washington, D.C. 20549 To Whom It May Concern: We have read the following paragraphs of Item 4.01 included in the Form 8-K filed February 24, 2005 of Nutra Pharma Corp. and we are in agreement with the statements contained in these paragraphs: o (a)(1) (i) and (ii) o (a)(1) (iv) (A) o (a)(3) We have no basis to agree or disagree with Item 4.01, paragraphs (a)(1)(iii) and (a)(2). Very truly yours, /s/ Eisner LLP Eisner LLP
- NPHC Dashboard
- Financials
- Filings
- Insider
- Institutional
- Patents
-
8-K Filing
Nutra Pharma (NPHC) 8-KChanges in Registrant.s Certifying Accountant
Filed: 24 Feb 05, 12:00am